Botulinum Neurotoxin-Specific Capture Agents, Compositions, And Methods Of Using And Making

Patent No. EP3270951 (titled "Botulinum Neurotoxin-Specific Capture Agents, Compositions, And Methods Of Using And Making") was filed by California Institute OF Technology on Mar 16, 2016. The application was issued on Sep 9, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MERZ PHARMAJun 9, 2021ALTMANN STOSSEL DICK PATENTANWALTE PARTG MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3270951

CALIFORNIA INSTITUTE OF TECHNOLOGY
Application Number
EP16713229A
Filing Date
Mar 16, 2016
Status
Revoked
Apr 14, 2023
Publication Date
Sep 9, 2020